BRIDGEWATER, N.J., March 1, 2018 /PRNewswire/ — Amneal Pharmaceuticals has launched oseltamivir phosphate for oral suspension, the company’s AB-rated therapeutic equivalent for Tamiflu®, in a 6 mg/mL strength. The powder finished dosage form is made in the U.S.A. and packaged in bottles…
The World's #1 Mining Property Marketplace
Established 2009 — Connecting Buyers and Sellers Worldwide
